357
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes

, , , &

References

  • American Academy of Pediatrics, Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. (2001). Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics, 108(4), 1033–1044.
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
  • Barkley, R. A. (2007). What may be in store for DSM-V. The ADHD Report, 15(4), 1–7.
  • Bell, A. S. (2011). A critical review of ADHD diagnostic criteria: What to address in the DSM-V. Journal of Attention Disorders, 15(1), 3–10.
  • Carlson, C. L., Shin, M., & Booth, J. (1999). The case for DSM‐IV subtypes in ADHD. Mental Retardation and Developmental Disabilities Research Reviews, 5(3), 199–206.
  • Charach, A., Yeung, E., Climans, T., & Lillie, E. (2011). Childhood attention-deficit/hyperactivity disorder and future substance use disorders: Comparative meta-analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 50(1), 9–21.
  • Connor, D. F. (2012). Aggression and antisocial behavior in children and adolescents: Research and treatment. New York, NY: Guilford Press.
  • Cumyn, L., French, L., & Hechtman, L. (2009). Comorbidity in adults with attention-deficit hyperactivity disorder. The Canadian Journal of Psychiatry, 54(10), 673–683.
  • De Alwis, D., Lynskey, M. T., Reiersen, A. M., & Agrawal, A. (2014). Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addictive Behaviors, 39(8), 1278–1285.
  • Elkins, I. J., McGue, M., & Iacono, W. G. (2007). Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General Psychiatry, 64(10), 1145–1152.
  • Faraone, S. V., & Wilens, T. (2003). Does stimulant treatment lead to substance use disorders? Journal of Clinical Psychiatry, 64(Suppl 11), 9–13.
  • Foster, I., Racicot, S., & McGrath, J. J. (2012). Attention-deficit/hyperactivity disorder subtype differentially predicts smoking expectancies in adolescents. Journal of Adolescent Health, 51(4), 393–399.
  • Fuemmeler, B. F., Kollins, S. H., & McClernon, F. J. (2007). Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. Journal of Pediatric Psychology, 32(10), 1203–1213.
  • Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992). Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin, 112(1), 64–105.
  • Humphreys, K. L., Eng, T., & Lee, S. S. (2013). Stimulant medication and substance use outcomes: A meta-analysis. JAMA Psychiatry, 70(7), 740–749.
  • Kaplan, H. B., & Johnson, R. J. (1992). Relationships between circumstances surrounding initial illicit drug use and escalation of drug use: Moderating effects of gender and early adolescent experiences. In M. D. Glantz & R. W. Pickens (Eds.), Vulnerability to drug abuse (pp. 299–358). Washington, DC: American Psychological Association.
  • Kessler, R. C., Avenevoli, S., Costello, E. J., Green, J. G., Gruber, M. J., Heeringa, S., . . . Zaslavsky, A. M. (2009). National comorbidity survey replication adolescent supplement (NCS-A): II. overview and design. Journal of the American Academy of Child & Adolescent Psychiatry, 48(4), 380–385.
  • Kessler, R. C., Avenevoli, S., Green, J., Gruber, M. J., Guyer, M., He, Y., . . . Zaslavsky, A. M. (2009). National comorbidity survey replication adolescent supplement (NCS-A): III. concordance of DSM-IV/CIDI diagnoses with clinical reassessments. Journal of the American Academy of Child & Adolescent Psychiatry, 48(4), 386–399.
  • Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31(3), 328–341.
  • McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2012). Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. Archives of General Psychiatry, 69(11), 1151–1160.
  • Merikangas, K. R., He, J., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L.,… Swendsen, J. (2010). Lifetime prevalence of mental disorders in US adolescents: Results from the national comorbidity survey Replication–Adolescent supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 49(10), 980–989.
  • Molina, B. S., & Pelham, W. E., Jr. (2003). Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of Abnormal Psychology, 112(3), 497–507.
  • Murphy, K. R., Barkley, R. A., & Bush, T. (2002). Young adults with attention deficit hyperactivity disorder: Subtype differences in comorbidity, educational, and clinical history. The Journal of Nervous and Mental Disease, 190(3), 147–157.
  • Needle, R., McCubbin, H., Lorence, J., & Hochhauser, M. (1983). Reliability and validity of adolescent self-reported drug use in a family-based study: A methodological report. International Journal of the Addictions, 18(7), 901–912.
  • Reboussin, B. A., & Ialongo, N. S. (2010). Latent transition models with latent class predictors: Attention deficit hyperactivity disorder subtypes and high school marijuana use. Journal of the Royal Statistical Society: Series A (Statistics in Society), 173(1), 145–164.
  • Riggs, P. D. (2014). Stimulant medication for ADHD not associated with subsequent substance use disorders. Evidence-Based Medicine, 19(2), 78.
  • Sawyer, M., Rey, J., Graetz, B., Clark, J., & Baghurst, P. (2002). Use of medication by young people with attention-deficit/hyperactivity disorder. Medical Journal of Australia, 177(1), 21–25.
  • Sobanski, E., Brüggemann, D., Alm, B., Kern, S., Philipsen, A., Schmalzried, H.,… Rietschel, M. (2008). Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. European Psychiatry, 23(2), 142–149.
  • Tamm, L., Adinoff, B., Nakonezny, P. A., Winhusen, T., & Riggs, P. (2012). Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. The American Journal of Drug and Alcohol Abuse, 38(1), 93–100.
  • Visser, S. N., Bitsko, R. H., Danielson, M. L., Perou, R., & Blumberg, S. J. (2010). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. Morbidity and Mortality Weekly Report, 59(44), 1439–1443.
  • Weiss, R. D., Najavits, L. M., Greenfield, S. F., Soto, J. A., Shaw, S. R., & Wyner, D. (1998). Validity of substance use self-reports in dually diagnosed outpatients. American Journal of Psychiatry, 155(1), 127–128.
  • Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179–185.
  • Willcutt, E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499.
  • Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biological Psychiatry, 57(11), 1336–1346.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.